Release Date: 26/03/24 20:10 Summary: Becoming a substantial holder from MS Price Sensitive: No Download Document 319.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%